Cited by 57Thyroid Disorders and TreatmentsAdipose Tissue and MetabolismMitochondrial Function and Pathology

Effect of Short-Term Thyroxine Administration on Energy Metabolism and Mitochondrial Efficiency in Humans

Open access
Johannsen, Darcy L., Galgani, Jose E., Johannsen, Neil M., Zhang, Zhengyu, Covington, Jeffrey D., Ravussin, Eric·2012·PLoS ONE

Abstract

The physiologic effects of triiodothyronine (T3) on metabolic rate are well-documented; however, the effects of thyroxine (T4) are less clear despite its wide-spread use to treat thyroid-related disorders and other non-thyroidal conditions. Here, we investigated the effects of acute (3-day) T4 supplementation on energy expenditure at rest and during incremental exercise. Furthermore, we used a combination of in situ and in vitro approaches to measure skeletal muscle metabolism before and after T4 treatment. Ten healthy, euthyroid males were given 200 µg T4 (levothyroxine) per day for 3 days. Energy expenditure was measured at rest and during exercise by indirect calorimetry, and skeletal muscle mitochondrial function was assessed by in situ ATP flux ((31)P MRS) and in vitro respiratory control ratio (RCR, state 3/state 4 rate of oxygen uptake using a Clark-type electrode) before and after acute T4 treatment. Thyroxine had a subtle effect on resting metabolic rate, increasing it by 4% (p = 0.059) without a change in resting ATP demand (i.e., ATP flux) of the vastus lateralis. Exercise efficiency did not change with T4 treatment. The maximal capacity to produce ATP (state 3 respiration) and the coupled state of the mitochondria (RCR) were reduced by approximately 30% with T4 (p = 0.057 and p = 0.04, respectively). Together, the results suggest that T4, although less metabolically active than T3, reduces skeletal muscle efficiency and modestly increases resting metabolism even after short-term supplementation. Our findings may be clinically relevant given the expanding application of T4 to treat non-thyroidal conditions such as obesity and weight loss.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0040837

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Short-term studies of supraphysiologic thyroid hormone doses uniformly showed increased resting and 24-hour energy expenditure, but were too brief to document changes in body composition.

    “These studies uniformly showed increased resting and 24-hour energy expenditure, but were too brief to document changes in body composition.”
  • Most prior studies of supraphysiologic thyroid hormone doses utilized high doses of levotriiodothyronine (LT3), not minimally suppressive doses of LT4.

    “In addition, most utilized high doses of levotriiodothyronine (LT3), not minimally suppressive doses of LT4.”
  • Past studies have reported increased resting or 24-hour energy expenditure and whole body oxygen consumption with exogenous administration of pharmacologic doses of LT4 or LT3 to healthy humans due to increased expression of uncoupling proteins and decreased mitochondrial efficiency.

    “Past studies have reported increased resting or 24-hour energy expenditure and whole body oxygen consumption with exogenous administration of pharmacologic doses of LT4 or LT3 to healthy humans (3-7) due to increased expression of uncoupling proteins and decreased mitochondrial efficiency (3,4,7).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 35 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [20]Dubois S Abraham P Rohmer V Rodien P Audran M 2008 Thyroxine therapy in euthyroid patients does not affect body composition or muscular function. Thyroid 18 13 19 17988199
  2. [21]Ladenson PW Goldenheim PD Cooper DS Miller MA Ridgway EC 1982 Early peripheral responses to intravenous L-thyroxine in primary hypothyroidism. Am J Med 73 467 474 7124775

Cited by

Sorted by citations

Authors
Johannsen, D. L., Galgani, J. E., Johannsen, N. M., Zhang, Z., Covington, J. D., & Ravussin, E.
Affiliations
Pennington Biomedical Research Center (US)
Venue
PLoS ONE
Published
2012-07-26
Volume
7
Issue
7
Pages
e40837
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2078283606
Cited by
57
References
35
Citations by year
2026: 2 · 2025: 6 · 2024: 2 · 2023: 8 · 2022: 5 · 2021: 4 · 2020: 9 · 2019: 2 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 3 · 2014: 1 · 2013: 5
FWCI
2.31
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health
  • Nutrition Obesity Research Center, University of North Carolina
  • National Institute on Aging (P01AG022064, P01AG22064)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K01DK89005, K01DK089005, P30DK072476)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
thyroxine, levothyroxine, triiodothyronine, energy expenditure, resting metabolic rate, exercise efficiency, skeletal muscle metabolism, mitochondrial efficiency, respiratory control ratio, vastus lateralis, thyroid hormone replacement, obesity treatment
MeSH terms
Adult, Basal Metabolism, Energy Metabolism, Humans, Male, Mitochondria, Thyroxine, Time Factors, Exercise

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review